Hana Pharm Co., Ltd. (293480.KS) KSC
9,110.00
-250(-2.67%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Hana Pharm Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
730
First IPO Date
October 02, 2018
Key Executives
| Name | Title | Pay | Year Born |
| Taehong Choi | Pres, Chief Executive Officer & Director | 0 | N/A |
| Hong-Joo Yun | Director of Bus. Department, Chief Financial Officer & Director | 0 | N/A |
| Elia Cho | Director of Global Department & Director | 0 | N/A |
Description
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1958 and is headquartered in Seoul, South Korea.
